G-CSF alone mobilizes sufficient peripheral blood CD34+ cells for positive selection in newly diagnosed patients with myeloma and lymphoma

British Journal of Haematology

Volumn 92, Issue 2, 1996, Pages 263-268

  Mahe B ^a   Milpied, N ^b   Hermouet, S ^a   Robillard, N ^a   Moreau, P ^b   Letortorec, S ^b   Rapp, M J ^b   Bataille, R ^a   Harousseau, J L ^b  

^a INSTITUT DE BIOLOGIE   (France)

^b HÔTEL DIEU   (France)

Author keywords

Autologous transplantation; CD34+ cells; Follicular non Hodgkin's lymphoma; Multiple myeloma; Positive selection

Indexed keywords

CD34 ANTIGEN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; GRANULOCYTE COLONY STIMULATING FACTOR; MELPHALAN; PREDNISONE; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; VINCRISTINE;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CELL MOTILITY; CLINICAL ARTICLE; FEMALE; FLOW CYTOMETRY; GRANULOCYTE; HUMAN; LEUKAPHERESIS; MALE; MULTIPLE MYELOMA; NONHODGKIN LYMPHOMA; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; SUBCUTANEOUS DRUG ADMINISTRATION; THROMBOCYTE;

EID: 0030052991     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1996.d01-1506.x     Document Type: Article

References (12)

1. Bird, J.M., Bloxham, D., Samson, D., Marcus, R.E., Russel, N.H., Kelsey, S.M., Newland, A.C. & Apperley, J.F. (1994) Molecular detection of clonally rearranged cells in peripheral blood progenitor cells harvests from multiple myeloma patients. British Journal of Haematology, 88, 110-116.
2. Berenson, R.J., Bensinger, W.I. & Andrews, R.G. (1987) Hematopoietic stem cell transplants. Recent Advances in Leukemia and Lymphoma (ed. by R. P. Gale and D. W. Golde), pp. 527-533. Alan Liss, New York.
3. + cells and unseparated peripheral blood progenitor cells mediate identical hematopoietic engraftment after high-dose VP16, Ifosfamide, Carboplatin, and Epirubicin. Blood, 84, 1421-1426.
4. + human bone marrow hematopoietic cells with high recovery of early progenitors. Experimental Hematology, 23, 407-412.
5. Freedman, A.S., Ritz, J. & Neuberg, D. (1991) Autologous bone marrow transplantation in 69 patients with history of low-grade B-cell non-Hodgkin's lymphoma. Blood, 77, 2524-2529.
6. + bone marrow progenitor cells in patients with non-Hodgkin's lymphoma. Blood, 85, 1647-1654.
7. Gribben, J.G., Freedman, A.S., Woo, S.D., Blake, K., Shu, R.S., Freeman, G., Longtine, J.A., Pinkus, G.S. & Nadler, L.M. (1991) All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood, 78, 3275-3280.
8. Harousseau, J.L., Attal, M., Divine, M., Leblond, V., Stoppa, A.M., Bourhis, J.H., Caillot, D., Boasson, M., Abgrall, J.F., Facon, T., Linassier, C., Cahn, J.Y., Lamy, T., Troussard, X., Gratecos, N., Pignon, B., Auzanneau, G. & Bataille, R. (1995) Autologous stem cell transplantation after first remission induction treatment in multiple myeloma: a report of the French registry on autologous transplantation in multiple myeloma. Blood, 85, 3077-3085.
9. Lambrechts, A.C., Hupkes, P.E., Dorssers, L.C.J. & Van't Veer, M.B. (1993) Translocation (14; 18)-positive cells are present in the circulation of the majority of patients with localized (stages I and II) follicular non-Hodgkin's lymphoma. Blood, 82, 2510-25.
10. + cells with a different antigenic profile compared with use during steady-state hematopoiesis. Bone Marrow Transplantation, 14, 827-832.
11. Shpall, E.J., Jones, R.B., Bearman, S.C., Franklin, W.A., Archer, P.G., Curiel, T., Bitter, M., Claman, H.N., Stemmer, S.M., Purdy, M., Myers, S.E., Hami, L., Taffs, S., Heimfeld, S., Hallagan, J. & Berenson, R.J. (1994) Transplantation of enriched CD34-positive autologous marrow into breast cancer patients following high-dose chemotherapy: influence of CD34-positive peripheral-blood progenitors and growth factors on engraftment. Journal of Clinical Oncology, 12, 28-36.
12. Vescio, R.A., Hong, C.H., Cao, J., Kim, A., Schiller, G.J., Lichtenstein, A.K., Berenson, R.J. & Berenson, J.R. (1994) The hematopoietic stem cell antigen, CD34, is not expressed on the malignant cells in multiple myeloma. Blood, 84, 3283-329